SCHEMBL19457348

SCHEMBL19457348

C=CC(=O)Nc1ccc(S(=O)(=O)c2ccc(C)cc2)cc1

nearest known ligand 0.77

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TGM2 P21980 11/20 0.77
PKM P14618 1/20 0.66
F13A1 P00488 5/20 0.58
TGM1 P22735 5/20 0.58
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
ALDH1A1 P00352 2/20 0.53
LMNA P02545 1/20 0.53
TGM3 Q08188 1/20 0.53
MAPT P10636 1/20 0.53
POLB P06746 1/20 0.52
GAA P10253 1/20 0.52
PTPN7 P35236 1/20 0.51
NMT1 P30419 1/20 0.50
ATM Q13315 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL648950 0.88 TGM2 (1.00) TGM2F13A1TGM1ALDH1A1LMNA
SCHEMBL3821674 0.86 ALDH1A1 (0.71) TGM2MEN1KMT2AALDH1A1LMNA
SCHEMBL9568792 0.86 ALDH1A1 (0.71) TGM2MEN1KMT2AALDH1A1LMNA
SCHEMBL19457358 0.86 NAMPT (0.61) TGM2PKMF13A1TGM1MEN1
SCHEMBL19457350 0.86 TGM2 (0.56) TGM2PKMF13A1TGM1MEN1
SCHEMBL7894169 0.85 TGM2 (0.66) TGM2F13A1TGM1LMNATGM3
SCHEMBL964754 0.84 TGM2 (0.64) TGM2PKMF13A1TGM1LMNA
SCHEMBL20885056 0.83 TGM2 (0.63) TGM2PKMF13A1TGM1ALDH1A1
SCHEMBL8465028 0.83 TGM2 (0.89) TGM2F13A1TGM1ALDH1A1LMNA
SCHEMBL17327893 0.83 TGM2 (0.69) TGM2F13A1TGM1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3440084-B1 PYRIMIDO-DIAZEPINONE KINASE SCAFFOLD COMPOUNDS AND METHODS OF TREATING PI3K-MEDIATED DISORDERS DANA FARBER CANCER INST INC (US) 2022-12-21 EP disclosed
WO-2017177092-A1 PYRIMIDO-DIAZEPINONE KINASE SCAFFOLD COMPOUNDS AND METHODS OF TREATING PI3K-MEDIATED DISORDERS DANA-FARBER CANCER INSTITUTE, INC. (US) 2017-10-12 WO disclosed
CN-102256792-B Radiation-sensitive compositions and elements containing poly(vinyl hydroxyaryl carboxylic acid ester)s EASTMAN KODAK CO 2014-08-20 CN disclosed
CN-102256792-A Radiation-sensitive compositions and elements containing poly(vinyl hydroxyaryl carboxylic acid ester)s EASTMAN KODAK CO 2011-11-23 CN disclosed